United States Excess Deaths: No. of Deaths: New Jersey data was reported at 1,121.000 Number in 16 Sep 2023. This records a decrease from the previous number of 1,297.000 Number for 09 Sep 2023. United States Excess Deaths: No. of Deaths: New Jersey data is updated weekly, averaging 1,445.000 Number from Jan 2017 (Median) to 16 Sep 2023, with 350 observations. The data reached an all-time high of 4,774.000 Number in 11 Apr 2020 and a record low of 1,121.000 Number in 16 Sep 2023. United States Excess Deaths: No. of Deaths: New Jersey data remains active status in CEIC and is reported by Centers for Disease Control and Prevention. The data is categorized under Global Database’s United States – Table US.G010: Number of Excess Deaths: by States: All Causes (Discontinued).

United States Excess Deaths: Total Excess Estimate: New Jersey data was reported at 33,310.000 Number in 16 Sep 2023. This stayed constant from the previous number of 33,310.000 Number for 09 Sep 2023. United States Excess Deaths: Total Excess Estimate: New Jersey data is updated weekly, averaging 33,310.000 Number from Jan 2017 (Median) to 16 Sep 2023, with 350 observations. The data reached an all-time high of 33,310.000 Number in 16 Sep 2023 and a record low of 33,310.000 Number in 16 Sep 2023. United States Excess Deaths: Total Excess Estimate: New Jersey data remains active status in CEIC and is reported by Centers for Disease Control and Prevention. The data is categorized under Global Database’s United States – Table US.G010: Number of Excess Deaths: by States: All Causes (Discontinued).

United States Excess Death excl COVID: Predicted: Single Estimate: New Jersey data was reported at 0.000 Number in 16 Sep 2023. This stayed constant from the previous number of 0.000 Number for 09 Sep 2023. United States Excess Death excl COVID: Predicted: Single Estimate: New Jersey data is updated weekly, averaging 0.000 Number from Jan 2017 (Median) to 16 Sep 2023, with 350 observations. The data reached an all-time high of 924.000 Number in 11 Apr 2020 and a record low of 0.000 Number in 16 Sep 2023. United States Excess Death excl COVID: Predicted: Single Estimate: New Jersey data remains active status in CEIC and is reported by Centers for Disease Control and Prevention. The data is categorized under Global Database’s United States – Table US.G012: Number of Excess Deaths: by States: All Causes excluding COVID-19: Predicted (Discontinued).

United States Excess Deaths: Upper Bound: New Jersey data was reported at 1,512.000 Number in 16 Sep 2023. This records an increase from the previous number of 1,508.000 Number for 09 Sep 2023. United States Excess Deaths: Upper Bound: New Jersey data is updated weekly, averaging 1,522.500 Number from Jan 2017 (Median) to 16 Sep 2023, with 350 observations. The data reached an all-time high of 1,684.000 Number in 16 Feb 2019 and a record low of 1,380.000 Number in 05 Aug 2017. United States Excess Deaths: Upper Bound: New Jersey data remains active status in CEIC and is reported by Centers for Disease Control and Prevention. The data is categorized under Global Database’s United States – Table US.G010: Number of Excess Deaths: by States: All Causes (Discontinued).

As of 2023, the third leading cause of death among teenagers aged 15 to 19 years in the United States was intentional self-harm or suicide, contributing to around 17 percent of deaths among this age group. The leading cause of death at that time was unintentional injuries, contributing to around 38.6 percent of deaths, while 20.7 percent of all deaths in this age group were due to assault or homicide. Cancer and heart disease, the overall leading causes of death in the United States, are also among the leading causes of death among U.S. teenagers. Adolescent suicide in the United States In 2021, around 22 percent of students in grades 9 to 12 reported that they had seriously considered attempting suicide in the past year. Female students were around twice as likely to report seriously considering suicide compared to male students. In 2023, New Mexico had the highest rate of suicides among U.S. teenagers, with around 28 deaths per 100,000 teenagers, followed by Idaho with a rate of 22.5 per 100,000. The states with the lowest death rates among adolescents are New Jersey and New York. Mental health treatment Suicidal thoughts are a clear symptom of mental health issues. Mental health issues are not rare among children and adolescents, and treatment for such issues has become increasingly accepted and accessible. In 2021, around 15 percent of boys and girls aged 5 to 17 years had received some form of mental health treatment in the past year. At that time, around 35 percent of youths aged 12 to 17 years in the United States who were receiving specialty mental health services were doing so because they had thought about killing themselves or had already tried to kill themselves.

United States Excess Deaths: Predicted: No. of Deaths: New Jersey data was reported at 1,367.000 Number in 16 Sep 2023. This records a decrease from the previous number of 1,435.000 Number for 09 Sep 2023. United States Excess Deaths: Predicted: No. of Deaths: New Jersey data is updated weekly, averaging 1,445.000 Number from Jan 2017 (Median) to 16 Sep 2023, with 350 observations. The data reached an all-time high of 4,774.000 Number in 11 Apr 2020 and a record low of 1,256.000 Number in 29 Jul 2017. United States Excess Deaths: Predicted: No. of Deaths: New Jersey data remains active status in CEIC and is reported by Centers for Disease Control and Prevention. The data is categorized under Global Database’s United States – Table US.G011: Number of Excess Deaths: by States: All Causes: Predicted (Discontinued).

Effective September 27, 2023, this dataset will no longer be updated. Similar data are accessible from wonder.cdc.gov.

Deaths involving COVID-19 reported to NCHS by time-period, HHS region, race and Hispanic origin, and age group.

United States death counts include the 50 states, plus the District of Columbia and New York City. The ten (10) United States Department of Health and Human Services (HHS) regions include the following jurisdictions. Region 1: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont; Region 2: New Jersey, New York, New York City, Puerto Rico; Region 3: Delaware, District of Columbia, Maryland, Pennsylvania, Virginia, West Virginia; Region 4: Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee; Region 5: Illinois, Indiana, Michigan, Minnesota, Ohio, Wisconsin; Region 6: Arkansas, Louisiana, New Mexico, Oklahoma, Texas; Region 7: Iowa, Kansas, Missouri, Nebraska; Region 8: Colorado, Montana, North Dakota, South Dakota, Utah, Wyoming; Region 9: Arizona, California, Hawaii, Nevada; Region 10: Alaska, Idaho, Oregon, Washington.

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Updated (Bivalent) Booster Status. Click 'More' for important dataset description and footnotes

Webpage: https://covid.cdc.gov/covid-data-tracker/#rates-by-vaccine-status

Dataset and data visualization details:

These data were posted and archived on May 30, 2023 and reflect cases among persons with a positive specimen collection date through April 22, 2023, and deaths among persons with a positive specimen collection date through April 1, 2023. These data will no longer be updated after May 2023.

Vaccination status: A person vaccinated with at least a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. A person vaccinated with a primary series and a monovalent booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably receiving a primary series of an FDA-authorized or approved vaccine and at least one additional dose of any monovalent FDA-authorized or approved COVID-19 vaccine on or after August 13, 2021. (Note: this definition does not distinguish between vaccine recipients who are immunocompromised and are receiving an additional dose versus those who are not immunocompromised and receiving a booster dose.) A person vaccinated with a primary series and an updated (bivalent) booster dose had SARS-CoV-2 RNA or antigen detected in a respiratory specimen collected ≥14 days after verifiably receiving a primary series of an FDA-authorized or approved vaccine and an additional dose of any bivalent FDA-authorized or approved vaccine COVID-19 vaccine on or after September 1, 2022. (Note: Doses with bivalent doses reported as first or second doses are classified as vaccinated with a bivalent booster dose.) People with primary series or a monovalent booster dose were combined in the “vaccinated without an updated booster” category.

Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Per the interim guidance of the Council of State and Territorial Epidemiologists (CSTE), this should include persons whose death certificate lists COVID-19 disease or SARS-CoV-2 as the underlying cause of death or as a significant condition contributing to death. Rates of COVID-19 deaths by vaccination status are primarily reported based on when the patient was tested for COVID-19. In select jurisdictions, deaths are included that are not laboratory confirmed and are reported based on alternative dates (i.e., onset date for most; or date of death or report date, where onset date is unavailable). Deaths usually occur up to 30 days after COVID-19 diagnosis.

Participating jurisdictions: Currently, these 24 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Colorado, District of Columbia, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (NY), North Carolina, Rhode Island, Tennessee, Texas, Utah, and West Virginia; 23 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 48% of the total U.S. population and all ten of the Health and Human Services Regions. This list will be

United States Excess Deaths: Single Excess Estimate: New Jersey data was reported at 0.000 Number in 16 Sep 2023. This stayed constant from the previous number of 0.000 Number for 09 Sep 2023. United States Excess Deaths: Single Excess Estimate: New Jersey data is updated weekly, averaging 20.000 Number from Jan 2017 (Median) to 16 Sep 2023, with 350 observations. The data reached an all-time high of 3,300.000 Number in 11 Apr 2020 and a record low of 0.000 Number in 16 Sep 2023. United States Excess Deaths: Single Excess Estimate: New Jersey data remains active status in CEIC and is reported by Centers for Disease Control and Prevention. The data is categorized under Global Database’s United States – Table US.G010: Number of Excess Deaths: by States: All Causes (Discontinued).

As of March 10, 2023, the death rate from COVID-19 in the state of New York was 397 per 100,000 people. New York is one of the states with the highest number of COVID-19 cases.

United States Excess Deaths: Predicted: Single Excess Estimate: New Jersey data was reported at 0.000 Number in 16 Sep 2023. This records a decrease from the previous number of 17.000 Number for 09 Sep 2023. United States Excess Deaths: Predicted: Single Excess Estimate: New Jersey data is updated weekly, averaging 20.000 Number from Jan 2017 (Median) to 16 Sep 2023, with 350 observations. The data reached an all-time high of 3,300.000 Number in 11 Apr 2020 and a record low of 0.000 Number in 16 Sep 2023. United States Excess Deaths: Predicted: Single Excess Estimate: New Jersey data remains active status in CEIC and is reported by Centers for Disease Control and Prevention. The data is categorized under Global Database’s United States – Table US.G011: Number of Excess Deaths: by States: All Causes: Predicted (Discontinued).

Since the 1950s, the suicide rate in the United States has been significantly higher among men than women. In 2022, the suicide rate among men was almost four times higher than that of women. However, the rate of suicide for both men and women has increased gradually over the past couple of decades. Facts on suicide in the United States In 2022, the rate of suicide death in the United States was around 14 per 100,000 population. The suicide rate in the U.S. has generally increased since the year 2000, with the highest rates ever recorded in the years 2018 and 2022. In the United States, death rates from suicide are highest among those aged 45 to 64 years and lowest among younger adults aged 15 to 24. The states with the highest rates of suicide are Montana, Alaska, and Wyoming, while New Jersey and Massachusetts have the lowest rates. Suicide among men In 2023, around 4.5 percent of men in the United States reported having serious thoughts of suicide in the past year. Although this rate is lower than that of women, men still have a higher rate of suicide death than women. One reason for this may have to do with the method of suicide. Although firearms account for the largest share of suicide deaths among both men and women, firearms account for almost 60 percent of all suicides among men and just 35 percent among women. Suffocation and poisoning are the other most common methods of suicide among women, with the chances of surviving a suicide attempt from these methods being much higher than surviving an attempt by firearm. The age group with the highest rate of suicide death among men is by far those aged 75 years and over.

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes

Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.

Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases among people who received additional or booster doses were reported from 31 jurisdictions; 30 jurisdictions also reported data on deaths among people who received one or more additional or booster dose; 28 jurisdictions reported cases among people who received two or more additional or booster doses; and 26 jurisdictions reported deaths among people who received two or more additional or booster doses. This list will be updated as more jurisdictions participate. Incidence rate estimates: Weekly age-specific incidence rates by vaccination status were calculated as the number of cases or deaths divided by the number of people vaccinated with a primary series, overall or with/without a booster dose (cumulative) or unvaccinated (obtained by subtracting the cumulative number of people vaccinated with a primary series and partially vaccinated people from the 2019 U.S. intercensal population estimates) and multiplied by 100,000. Overall incidence rates were age-standardized using the 2000 U.S. Census standard population. To estimate population counts for ages 6 months through 1 year, half of the single-year population counts for ages 0 through 1 year were used. All rates are plotted by positive specimen collection date to reflect when incident infections occurred. For the primary series analysis, age-standardized rates include ages 12 years and older from April 4, 2021 through December 4, 2021, ages 5 years and older from December 5, 2021 through July 30, 2022 and ages 6 months and older from July 31, 2022 onwards. For the booster dose analysis, age-standardized rates include ages 18 years and older from September 19, 2021 through December 25, 2021, ages 12 years and older from December 26, 2021, and ages 5 years and older from June 5, 2022 onwards. Small numbers could contribute to less precision when calculating death rates among some groups. Continuity correction: A continuity correction has been applied to the denominators by capping the percent population coverage at 95%. To do this, we assumed that at least 5% of each age group would always be unvaccinated in each jurisdiction. Adding this correction ensures that there is always a reasonable denominator for the unvaccinated population that would prevent incidence and death rates from growing unrealistically large due to potential overestimates of vaccination coverage. Incidence rate ratios (IRRs): IRRs for the past one month were calculated by dividing the average weekly incidence rates among unvaccinated people by that among people vaccinated with a primary series either overall or with a booster dose. Publications: Scobie HM, Johnson AG, Suthar AB, et al. Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1284–1290. Johnson AG, Amin AB, Ali AR, et al. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021. MMWR Morb Mortal Wkly Rep 2022;71:132–138. Johnson AG, Linde L, Ali AR, et al. COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022. MMWR Morb Mortal Wkly Rep 2023;72:145–152. Johnson AG, Linde L, Payne AB, et al. Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months — 20 U.S. Jurisdictions, September 18, 2022–April 1, 2023. MMWR Morb Mortal Wkly Rep 2023;72:667–669.

As of 2022, the U.S. states with the highest death rates from suicide were Alaska, Montana, and Wyoming. In Wyoming and Montana, there were around **** and **** suicide deaths per 100,000 population, respectively. In comparison, in New Jersey, the state with the lowest suicide death rate, there were only around *** suicide deaths per 100,000 population. Differences in suicide rates by gender In the United States, there is a vast difference in suicide rates between men and women, with rates over *** times higher among men. However, rates of suicide for both men and women have increased over the past couple of decades. Among men, those aged 75 years and older have the highest suicide rates, with around ** deaths per 100,000 population in 2021. Among women, those aged 45 to 64 years have the highest rates of suicide death with *** deaths per 100,000 population. What is the most common method of suicide? In the United States, the most common method of suicide is with firearms, followed by suffocation and then poisoning. In 2022, there were around ****** suicide deaths from firearms in the United States, compared to ****** deaths from suffocation and ***** from drug poisoning. In 2021, firearms accounted for around ** percent of suicide deaths among men. In comparison, around ** percent of deaths from suicide among women were due to firearms, while suffocation and poisoning each accounted for ** percent of such deaths.

As of March 10, 2023, there have been 1.1 million deaths related to COVID-19 in the United States. There have been 101,159 deaths in the state of California, more than any other state in the country – California is also the state with the highest number of COVID-19 cases.

The vaccine rollout in the U.S. Since the start of the pandemic, the world has eagerly awaited the arrival of a safe and effective COVID-19 vaccine. In the United States, the immunization campaign started in mid-December 2020 following the approval of a vaccine jointly developed by Pfizer and BioNTech. As of March 22, 2023, the number of COVID-19 vaccine doses administered in the U.S. had reached roughly 673 million. The states with the highest number of vaccines administered are California, Texas, and New York.

Vaccines achieved due to work of research groups Chinese authorities initially shared the genetic sequence to the novel coronavirus in January 2020, allowing research groups to start studying how it invades human cells. The surface of the virus is covered with spike proteins, which enable it to bind to human cells. Once attached, the virus can enter the cells and start to make people ill. These spikes were of particular interest to vaccine manufacturers because they hold the key to preventing viral entry.

United States Excess Deaths: Predicted: Avg Expected No. of Deaths: New Jersey data was reported at 1,421.000 Number in 16 Sep 2023. This records an increase from the previous number of 1,418.000 Number for 09 Sep 2023. United States Excess Deaths: Predicted: Avg Expected No. of Deaths: New Jersey data is updated weekly, averaging 1,428.000 Number from Jan 2017 (Median) to 16 Sep 2023, with 350 observations. The data reached an all-time high of 1,586.000 Number in 06 Feb 2021 and a record low of 1,292.000 Number in 05 Aug 2017. United States Excess Deaths: Predicted: Avg Expected No. of Deaths: New Jersey data remains active status in CEIC and is reported by Centers for Disease Control and Prevention. The data is categorized under Global Database’s United States – Table US.G011: Number of Excess Deaths: by States: All Causes: Predicted (Discontinued).

United States Excess Deaths excl COVID: Predicted: No. of Deaths: New Jersey data was reported at 1,335.000 Number in 16 Sep 2023. This records a decrease from the previous number of 1,401.000 Number for 09 Sep 2023. United States Excess Deaths excl COVID: Predicted: No. of Deaths: New Jersey data is updated weekly, averaging 1,407.000 Number from Jan 2017 (Median) to 16 Sep 2023, with 350 observations. The data reached an all-time high of 2,398.000 Number in 11 Apr 2020 and a record low of 1,241.000 Number in 29 May 2021. United States Excess Deaths excl COVID: Predicted: No. of Deaths: New Jersey data remains active status in CEIC and is reported by Centers for Disease Control and Prevention. The data is categorized under Global Database’s United States – Table US.G012: Number of Excess Deaths: by States: All Causes excluding COVID-19: Predicted (Discontinued).

（停止更新）超额死亡：死亡人数：新泽西州在09-16-2023达1,121.000数量，相较于09-09-2023的1,297.000数量有所下降。（停止更新）超额死亡：死亡人数：新泽西州数据按周更新，01-07-2017至09-16-2023期间平均值为1,445.000数量，共350份观测结果。该数据的历史最高值出现于04-11-2020，达4,774.000数量，而历史最低值则出现于09-16-2023，为1,121.000数量。CEIC提供的（停止更新）超额死亡：死亡人数：新泽西州数据处于定期更新的状态，数据来源于Centers for Disease Control and Prevention，数据归类于全球数据库的美国 – Table US.G010: Number of Excess Deaths: by States: All Causes (Discontinued)。

（停止更新）ED：预期：死亡人数：新泽西州在09-16-2023达1,367.000数量，相较于09-09-2023的1,435.000数量有所下降。（停止更新）ED：预期：死亡人数：新泽西州数据按周更新，01-07-2017至09-16-2023期间平均值为1,445.000数量，共350份观测结果。该数据的历史最高值出现于04-11-2020，达4,774.000数量，而历史最低值则出现于07-29-2017，为1,256.000数量。CEIC提供的（停止更新）ED：预期：死亡人数：新泽西州数据处于定期更新的状态，数据来源于Centers for Disease Control and Prevention，数据归类于全球数据库的美国 – Table US.G011: Number of Excess Deaths: by States: All Causes: Predicted (Discontinued)。

（停止更新）超额死亡：Total Excess Estimate：新泽西州在09-16-2023达33,310.000数量，相较于09-09-2023的33,310.000数量保持不变。（停止更新）超额死亡：Total Excess Estimate：新泽西州数据按周更新，01-07-2017至09-16-2023期间平均值为33,310.000数量，共350份观测结果。该数据的历史最高值出现于09-16-2023，达33,310.000数量，而历史最低值则出现于09-16-2023，为33,310.000数量。CEIC提供的（停止更新）超额死亡：Total Excess Estimate：新泽西州数据处于定期更新的状态，数据来源于Centers for Disease Control and Prevention，数据归类于全球数据库的美国 – Table US.G010: Number of Excess Deaths: by States: All Causes (Discontinued)。